Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

New Aspects of Therapy of Hepatocellular Carcinoma Egyptian Patients

Ragaa Hosny Mohamad1*, Mohamad Gamil Abdelmoneim El-Said2, Zekry Khalid Zekry3, Amal Mohamad Al-Bastawesy4, Rashwan Mohamad Farag5, Hussien Abdel-RahmanAl-Mehdar6, Abdulbaset Abdelsalam Elfighia7, Yahia Mahmoud Ismail8, Elsayed Ibrahim Elshayeb 9, Abdel Fatah Mohsen Badawy10, Sabry Mohamad Sharawy1 and Mahmoud Mohamad Elmarzabani11
1Clinical Biochemistry, Cancer Biology, National Cancer Institute, Cairo University, Egypt
2Surgical Oncology National Cancer Institute, Cairo University, Egypt
3Medical Oncology, National Cancer Institute, Cairo University, Egypt
4Food Technology Research Centre, Cairo University, Egypt
5Medical Biochemistry, Ain Shams University, Egypt
6Faculty of science, Biology Department, Immunology Unit, King Abdulaziz University, Jeddah, Saudi Arabia
7Medical Biochemistry, Tripoli University, Libya
8Medical Oncology, National Cancer Institute, Cairo University, Egypt
9Internal Medicine, Faculty of Medicine, Menofyia University, Egypt
10Organic Chemistry, Petroleum Research Centre, Egypt
11Drug Research and Experimental Pharmacology, National Cancer Institute, Cairo University, Egypt
*Corresponding Author : Ragaa Hosny Mohamad Mohamadeen Al-Tahtawy
Cancer Biology Department
National Cancer Institute
Cairo University, Fom Al-Khalig Street
Post No:11234, Cairo, Egypt
Tel: 0020100185686
Fax: +0223644720
E-mail: ragaatahtawy@gmail.com/td>
Received May 14, 2014; Accepted December 30, 2014; Published January 06, 2015
Citation: Mohamad RH, El-Said MGA, Zekry ZK, Al-Bastawesy AM, Farag RM, et al. (2015) New Aspects of Therapy of Hepatocellular Carcinoma Egyptian Patients. Biochem Physiol 4:150. doi:10.4172/2168-9652.1000150
Copyright: © 2015 Mohamad RH, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Background: The purpose of this study was design to investigate the potential impact of chemo and hormonal therapy drugs either with natural oils or other with vitamin E on HCC Egyptian patients.

Methods: A retrospective analysis of medical records was performed on 100 unresectable HCC Egyptian patients in stage A or B who were identified through the National Cancer Institute Cairo University and Menoufia University, from 2010 to 2013. All of patients had been received systemic chemo and hormonal and therapy (5-fluorouracil, Oxaloplatin and tamoxifen) either with five type of natural oils or other with vitamin E. Clinical picture , hematological test, metabolic parameters, telomerase activity, VEGF, MAD, GSH, zinc, ER ,PR, KRAS, BRAF and NRAS has been assessed. Survival curves were also analyzed at pre-and post-treatment. All patients were applied to do regular exercise, control their diet before receiving treatment. The survival rate was determined.

Results: the present data indicate that oral NS.O and CUR.O showed greatly kept hematological finding, serum levels of telomerase activity, VEGF, GSH, MAD ALT, AST, GGT, bilirubin, albumin and zinc to the normal levels (p < 0.001), the toxicity has been reduced without affecting response to chemo and hormonal therapy and survival , the quality of life, clinical picture and survival seemed to be better.Fortunately the depletion in the serum levels of the VEGF and the telomerase activity correlates with good of clinical picture compared with other groups under investigation.

Conclusion: Using Chemo and hormonal therapy, in combination with oral NS.O and CUR.O was identified as the most suitable treatment for HCC patients resulted in improving survival, maximizing clinical benefit, and minimizing risk of chemo and hormonal therapy toxicity. The telomerase activity and VEGF levels can be used as markers to predict survival and response to treatment in HCC patients in the future.

Keywords

Google Scholar citation report
Citations :

Biochemistry & Physiology: Open Access received citations as per Google Scholar report

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Scholarsteer
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Euro Pub
  • ICMJE
Share This Page
Top